Advertisement
Advertisement

TWST

TWST logo

Twist Bioscience Corporation Common Stock

46.80
USD
Sponsored
+5.73
+13.94%
Feb 02, 16:00 UTC -5
Closed
exchange

After-Market

46.76

-0.03
-0.07%

TWST Earnings Reports

Positive Surprise Ratio

TWST beat 18 of 30 last estimates.

60%

Next Report

Date of Next Report
May 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$107.95M
/
-$0.43
Implied change from Q1 26 (Revenue/ EPS)
+4.10%
/
-14.00%
Implied change from Q2 25 (Revenue/ EPS)
+16.34%
/
-34.85%

Twist Bioscience Corporation Common Stock earnings per share and revenue

On Feb 02, 2026, TWST reported earnings of -0.50 USD per share (EPS) for Q1 26, missing the estimate of -0.43 USD, resulting in a -14.00% surprise. Revenue reached 103.70 million, compared to an expected 102.82 million, with a 0.86% difference.
Looking ahead to Q2 26, 11 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 107.95 million USD, implying an decrease of -14.00% EPS, and increase of 4.10% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q1 2026, Twist Bioscience Corporation Common Stock reported EPS of -$0.50, missing estimates by -14%, and revenue of $103.70M, 0.86% above expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for May 04, 2026.
Based on 11 analysts, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.43 and revenue of $107.95M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement